171 related articles for article (PubMed ID: 12622318)
1. Translating worldwide calcium-channel blocker experience into clinical practice.
Zanchetti A
Clin Cardiol; 2003 Feb; 26(2 Suppl 2):II1-2. PubMed ID: 12622318
[No Abstract] [Full Text] [Related]
2. Effects of Long- and Intermediate-Acting Dihydropyridine Calcium Channel Blockers in Hypertension: A Systematic Review and Meta-Analysis of 18 Prospective, Randomized, Actively Controlled Trials.
Chaugai S; Sherpa LY; Sepehry AA; Kerman SRJ; Arima H
J Cardiovasc Pharmacol Ther; 2018 Sep; 23(5):433-445. PubMed ID: 29739234
[TBL] [Abstract][Full Text] [Related]
3. Nisoldipine--a new calcium channel blocker for hypertension.
Med Lett Drugs Ther; 1996 Feb; 38(968):13-4. PubMed ID: 8592476
[TBL] [Abstract][Full Text] [Related]
4. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
[TBL] [Abstract][Full Text] [Related]
5. Calcium channel blocker compared with angiotensin receptor blocker for patients with hypertension: a meta-analysis of randomized controlled trials.
Wu L; Deng SB; She Q
J Clin Hypertens (Greenwich); 2014 Nov; 16(11):838-45. PubMed ID: 25098737
[TBL] [Abstract][Full Text] [Related]
6. Calcium channel blocker-based combination therapy. The best approach in the treatment of high-risk hypertension?
Escobar C; Barrios V
Int J Clin Pract; 2008 May; 62(5):670-2. PubMed ID: 18412928
[No Abstract] [Full Text] [Related]
7. Hypertension is not all alike nor are its treatments: where would a better calcium-channel blocker fit in a modern treatment system?
Laragh JH
Clin Cardiol; 2003 Feb; 26(2 Suppl 2):II21-2. PubMed ID: 12622323
[No Abstract] [Full Text] [Related]
8. What have we learned from the calcium channel blocker controversy?
Califf RM; Kramer JM
Circulation; 1998 Apr; 97(16):1529-31. PubMed ID: 9593555
[No Abstract] [Full Text] [Related]
9. [Lacidipine: a new third generation calcium channel blocker].
Vertkin AL; Topolianskiĭ AV
Kardiologiia; 2002; 42(2):100-3. PubMed ID: 14587530
[No Abstract] [Full Text] [Related]
10. The calcium channel blocker controversy--caveats for the practitioner and pharmacist.
Bhagat K
Cent Afr J Med; 2000 Jun; 46(6):169-70. PubMed ID: 11235061
[No Abstract] [Full Text] [Related]
11. Pharmacotherapy review: calcium channel blockers.
Sica DA
J Clin Hypertens (Greenwich); 2006 Jan; 8(1):53-6. PubMed ID: 16407690
[TBL] [Abstract][Full Text] [Related]
12. Magnesium supplementation as an adjuvant to synthetic calcium channel antagonists in the treatment of hypertension.
Touyz RM
Med Hypotheses; 1991 Oct; 36(2):140-1. PubMed ID: 1664038
[TBL] [Abstract][Full Text] [Related]
13. [Mibefradil--a T-type calcium channel blocker].
Roguin A; Edoute Y
Harefuah; 1999 Jan; 136(2):167-9. PubMed ID: 10914190
[No Abstract] [Full Text] [Related]
14. Current perspective on the use of calcium channel blockers to treat hypertensive patients: the role of lercanidipine.
Mancia G; Tsioufis K
Future Cardiol; 2019 Jul; 15(4):259-266. PubMed ID: 31180724
[TBL] [Abstract][Full Text] [Related]
15. The development of new-onset type 2 diabetes associated with choosing a calcium channel blocker compared to a diuretic or beta-blocker.
Kuti EL; Baker WL; White CM
Curr Med Res Opin; 2007 Jun; 23(6):1239-44. PubMed ID: 17559720
[TBL] [Abstract][Full Text] [Related]
16. Use of digoxin, diuretics, beta blockers, angiotensin-converting enzyme inhibitors, and calcium channel blockers in older patients in an academic hospital-based geriatrics practice.
Fishkind D; Paris BE; Aronow WS
J Am Geriatr Soc; 1997 Jul; 45(7):809-12. PubMed ID: 9215330
[TBL] [Abstract][Full Text] [Related]
17. Calcium channel blocker therapy in black hypertensive patients.
Brewster LM; van Montfrans GA
Am J Hypertens; 2010 Mar; 23(3):218; author reply 219. PubMed ID: 20154647
[No Abstract] [Full Text] [Related]
18. Analysis of recent papers in hypertension. An angiotensin receptor blocker is more effective than a calcium channel blocker in secondary stroke prevention.
Bloch MJ; Basile J
J Clin Hypertens (Greenwich); 2005 Aug; 7(8):489-92. PubMed ID: 16103761
[No Abstract] [Full Text] [Related]
19. Successful management of refractory hypertension with dual calcium channel blocker therapy: case presentation.
Geurian K; Lipschitz D
Arch Fam Med; 1997; 6(5):503-5; discussion 506. PubMed ID: 9305698
[No Abstract] [Full Text] [Related]
20. Role of calcium channel blockers in the management of hypertension; and Calcium channel blockers: their evolving role in the management of hypertension. Proceedings of two symposiums. November 10, 1985, Washington, D.C.; and March 6-8, 1986, Key Biscayne, Florida.
Am J Med; 1986 Dec; 81(6A):1-42. PubMed ID: 3799660
[No Abstract] [Full Text] [Related]
[Next] [New Search]
